| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone from soy, has been shown to inhibit glycosphingolipid synthesis, possibly affecting GM2/GD2 production. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMPK activators like AICAR can influence lipid metabolism, which may indirectly affect GM2/GD2 synthase activity through metabolic changes. | ||||||
Fumonisin B1 | 116355-83-0 | sc-201395 sc-201395A | 1 mg 5 mg | $200.00 $680.00 | 18 | |
Fumonisin B1, a mycotoxin, inhibits ceramide synthase, which could indirectly influence GM2/GD2 synthase activity by altering sphingolipid levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of Vitamin A, influences cell differentiation and may indirectly affect GM2/GD2 synthase activity in developing neural tissues. | ||||||
L-β-Chloroalanine Methyl Ester Hydrochloride | 17136-54-8 | sc-211691 | 100 mg | $180.00 | ||
As a cysteine synthesis inhibitor, β-Chloroalanine could indirectly affect glycosphingolipid synthesis, potentially impacting GM2/GD2 synthase. | ||||||
Myriocin (ISP-1) | 35891-70-4 | sc-201397 | 10 mg | $150.00 | 8 | |
Myriocin, a potent inhibitor of serine palmitoyltransferase, can influence sphingolipid metabolism, potentially affecting GM2/GD2 synthase activity. | ||||||
4-Hydroxyphenylretinamide | 65646-68-6 | sc-200900 sc-200900A | 5 mg 25 mg | $104.00 $315.00 | ||
Fenretinide, a synthetic retinoid, has been shown to alter lipid metabolism, which might indirectly influence GM2/GD2 synthase activity. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, primarily known for its use in breast cancer, can affect lipid metabolism, potentially influencing GM2/GD2 synthase activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib, a tyrosine kinase inhibitor, might have indirect effects on GM2/GD2 synthase through its broader influence on cellular signaling pathways. | ||||||